Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What are Viruses?00:50

What are Viruses?

127.7K
Overview
127.7K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

9.0K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.0K
Tonicity in Animals00:59

Tonicity in Animals

123.3K
The tonicity of a solution determines if a cell gains or loses water in that solution. The tonicity depends on the permeability of the cell membrane for different solutes and the concentration of nonpenetrating solutes in the solution within and outside of the cell. If a semipermeable membrane hinders the passage of some solutes but allows water to follow its concentration gradient, water moves from the side with low osmolarity (i.e., less solute) to the side with higher osmolarity (i.e.,...
123.3K
Tonicity in Animals01:16

Tonicity in Animals

5.1K
Tonicity describes the amount of solute in a solution. The measure of the tonicity of a solution, or the total amount of solutes dissolved in a specific amount of solution, is called its osmolarity. Three terms—hypotonic, isotonic, and hypertonic—are used to relate the osmolarity of a cell to the osmolarity of the extracellular fluid that contains the cells. In a hypotonic solution, such as tap water, the extracellular fluid has a lower concentration of solutes than the fluid inside...
5.1K
Infection01:20

Infection

11.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.9K
Introduction to Virus01:28

Introduction to Virus

1.3K
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates.

Science advances·2023
Same author

Assessing the Ability of Human Dendritic Cells to Stimulate Naive CD4<sup>+</sup> and CD8<sup>+</sup> T Cells.

Methods in molecular biology (Clifton, N.J.)·2023
Same author

Development of a nonhuman primate model for mammalian bornavirus infection.

PNAS nexus·2022
Same author

Three-Week Old Pigs Are Not Susceptible to Productive Infection with SARS-COV-2.

Microorganisms·2022
Same author

UK B.1.1.7 (Alpha) variant exhibits increased respiratory replication and shedding in nonhuman primates.

Emerging microbes & infections·2021
Same author

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates.

bioRxiv : the preprint server for biology·2021

Related Experiment Video

Updated: Jan 20, 2026

Animal Model of Implant-Associated Infections in Mice
07:02

Animal Model of Implant-Associated Infections in Mice

Published on: June 27, 2025

861

Animal models for Lassa virus infection.

Tsing-Lee Tang-Huau1, H Feldmann2, K Rosenke1

  • 1Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, MT, USA.

Current Opinion in Virology
|August 24, 2019
PubMed
Summary
This summary is machine-generated.

Lassa virus causes severe hemorrhagic disease with no approved treatments. Mouse models are crucial for studying Lassa virus infection and host responses in high-containment labs, aiding future therapeutic development.

More Related Videos

Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.7K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Related Experiment Videos

Last Updated: Jan 20, 2026

Animal Model of Implant-Associated Infections in Mice
07:02

Animal Model of Implant-Associated Infections in Mice

Published on: June 27, 2025

861
Influenza A Virus Studies in a Mouse Model of Infection
10:44

Influenza A Virus Studies in a Mouse Model of Infection

Published on: September 7, 2017

29.7K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Area of Science:

  • Virology
  • Infectious Diseases
  • Animal Models

Background:

  • Lassa virus infection poses a significant threat to human health, characterized by hemorrhagic manifestations and high mortality rates.
  • Currently, there are no approved vaccines or treatments for Lassa virus.
  • Research on Lassa virus is restricted to high-containment biosafety level 4 (BSL4) laboratories due to its inherent danger.

Purpose of the Study:

  • To highlight the importance of animal models in Lassa virus research under BSL4 conditions.
  • To underscore the role of mouse models in understanding Lassa virus infection, disease progression, and host immune responses.
  • To emphasize the utility of guinea pigs and non-human primates in evaluating potential treatments and vaccines.

Main Methods:

  • Utilizing mouse models for in-depth study of Lassa virus infection dynamics.
  • Employing guinea pigs and non-human primates for preclinical assessment of therapeutic interventions and vaccine efficacy.
  • Conducting research within BSL4 containment facilities to ensure safety.

Main Results:

  • Mouse models provide valuable insights into Lassa virus pathogenesis and host responses.
  • Guinea pigs and non-human primates have demonstrated effectiveness in evaluating treatment and vaccine candidates.
  • The use of these animal models facilitates progress in Lassa virus countermeasure development.

Conclusions:

  • Mouse models are indispensable tools for Lassa virus research in high-containment settings.
  • Non-primate and primate models are critical for the validation of Lassa virus therapeutics and vaccines.
  • Advancements in understanding and combating Lassa virus rely heavily on these established animal models.